MA:NYSEMastercard Incorporated Analysis
Data as of 2026-07-03 - not real-time
$539.39
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Mastercard is trading just below its recent resistance around $540, with the price comfortably above the 20‑day and 50‑day SMAs and even the 200‑day SMA, suggesting short‑term momentum. However, the RSI sits at a lofty 71, flagging an overbought condition, and the MACD remains bullish with a strong histogram, indicating lingering upward pressure. The company posted 15.8% revenue growth, ultra‑high operating margins (over 60%) and robust free cash flow, but its ROE is modest at just over 2% and the balance sheet shows a high debt‑to‑equity ratio, raising efficiency concerns. Valuation metrics are stretched – the PE of 31 far exceeds the industry average of 17 and the price‑to‑book ratio of 71 is extreme, while the DCF model values the stock near $452, implying a ~19% downside from current levels. Recent material news includes a preliminary judicial approval of a $38 billion swipe‑fee settlement that could boost earnings, a dividend increase to $0.87 per share reinforcing income stability, and a leadership transition with Ling Hai moving to CFO, which may improve capital allocation. The market sentiment is in “Extreme Greed” mode, reflected by a fear‑greed index of 92.59, but the combination of high volatility (≈24% 30‑day) and low beta (≈0.4) suggests the stock could swing sharply on news. Overall, the stock appears overvalued in the near term despite strong fundamentals, making a cautious stance prudent while the long‑term growth narrative remains compelling.
Investors should weigh the near‑term overbought technical signals against the solid earnings backdrop and upcoming dividend payout, and consider a phased approach to exposure.
Investors should weigh the near‑term overbought technical signals against the solid earnings backdrop and upcoming dividend payout, and consider a phased approach to exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with overbought RSI
- Bullish MACD but high valuation premium
- Increasing volume supporting potential pullback
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and operating margins
- Dividend increase and low payout ratio
- Leadership transition that may enhance capital efficiency
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Network effects and scalable payment ecosystem
- Robust free cash flow generation
- Potential valuation compression toward DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth15.80%
Profit Margin45.88%
P/E Ratio31.3
ROE232.08%
ROA25.03%
Debt/Equity282.06
P/B Ratio71.2
Op. Cash Flow$18.3B
Free Cash Flow$16.1B
Industry P/E17.5
Technical Analysis
TrendBearish
RSI71.3
Support$477.46
Resistance$539.63
MA 20$496.68
MA 50$497.45
MA 200$531.14
MACDBullish
VolumeIncreasing
Fear & Greed Index92.59
Valuation
Fair Value$451.63
Target Price$643.59
Upside/Downside19.32%
GradeOvervalued
TypeGrowth
Dividend Yield0.65%
Risk Assessment
Beta0.39
Volatility23.84%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.